Your browser doesn't support javascript.
loading
Phenotypic screen identifies calcineurin-sparing FK506 analogs as BMP potentiators for treatment of acute kidney injury.
Larraufie, Marie-Hélène; Gao, Xiaolin; Xia, Xiaobo; Devine, Patrick J; Kallen, Joerg; Liu, Dong; Michaud, Gregory; Harsch, Andreas; Savage, Nik; Ding, Jian; Tan, Kian; Mihalic, Manuel; Roggo, Silvio; Canham, Stephen M; Bushell, Simon M; Krastel, Philipp; Gao, Jinhai; Izaac, Aude; Altinoglu, Erhan; Lustenberger, Philipp; Salcius, Michael; Harbinski, Fred; Williams, Eric T; Zeng, Liling; Loureiro, Joseph; Cong, Feng; Fryer, Christy J; Klickstein, Lloyd; Tallarico, John A; Jain, Rishi K; Rothman, Deborah M; Wang, Shaowen.
Afiliación
  • Larraufie MH; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Gao X; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Xia X; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Devine PJ; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Kallen J; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Liu D; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Michaud G; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Harsch A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Savage N; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Ding J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Tan K; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Mihalic M; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Roggo S; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Canham SM; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Bushell SM; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Krastel P; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Gao J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Izaac A; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Altinoglu E; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Lustenberger P; Novartis Global Drug Development, Basel, Switzerland.
  • Salcius M; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Harbinski F; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Williams ET; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Zeng L; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Loureiro J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Cong F; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Fryer CJ; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Klickstein L; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Tallarico JA; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Jain RK; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Rothman DM; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Wang S; Novartis Institutes for Biomedical Research, Cambridge, MA, USA. Electronic address: shaowen.wang@novartis.com.
Cell Chem Biol ; 28(9): 1271-1282.e12, 2021 09 16.
Article en En | MEDLINE | ID: mdl-33894161

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tacrolimus / Proteínas Morfogenéticas Óseas / Lesión Renal Aguda Límite: Animals / Humans / Male Idioma: En Revista: Cell Chem Biol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tacrolimus / Proteínas Morfogenéticas Óseas / Lesión Renal Aguda Límite: Animals / Humans / Male Idioma: En Revista: Cell Chem Biol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos